Delivery Order SPE2DB20D3103-SPE2DB24FP9M5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,526.36 Firm Fixed Price Delivery Order is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December...
- This federal contract award is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,989.50 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves to provide a wide range of pharmaceutical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical supply item. The contract has a ceiling value of $3,746.05 and is a firm fixed-price delivery order with a completion date of June 10, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp is the...
- This federal contract award is a Delivery Order valued at $10,882.86 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product, with a period of performance through June 16, 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price and a ceiling value of $5,730.00. It was awarded by the Defense Logistics Agency (DLA), a defense agency, for the supply of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is not set aside and has an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,993.80, is for the delivery of MULTIHANCE 529MG/ML 5S, a medical product. The contract has an ultimate completion date of March 29, 2024 and was awarded on March 4, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award is for the delivery of pharmaceutical products, specifically the medication Multihance 529 mg/ml vial 10ml, to the Defense Logistics Agency (DLA) for a total ceiling value of $3,054.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $5,792.88 and is a delivery order contract for the supply of a pharmaceutical product, MULTIHANCE 529MG/ML 5S. The contract has a period of performance through March 6, 2025 and is a firm fixed price contract. This award is associated with a larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, to provide MULTIHANCE 529 MG/ML VIAL 20ML, a specialty pharmaceutical product. The delivery order has a ceiling value of $1,189.20 and a period of performance through April 5, 2024. This award is a child contract under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, also awarded by DLA, with a potential...
- This federal contract award was issued by the Medical Supply Chain, an organization within the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,391.85, is a Firm Fixed Price Delivery Order for the procurement of PROHANCE 279.3 MG/ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FP9M5Delivery Order
This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The $11,466.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of August 20, 2024, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 8/19/24 |